These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7192214)

  • 21. Possibility of the transformation of eEF-2 (100 kDa) to eEF-2 (65 kDa) in the peptide elongation process in vitro.
    Gajko A; Sredzińska K; Galasiński W; Gindzieński A
    Biochem Biophys Res Commun; 1999 Feb; 255(2):535-8. PubMed ID: 10049743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Staurosporine and gossypol are inhibitors of the function of peptide elongation factor 1 alpha from rabbit reticulocytes.
    Tuhácková Z
    Biochem Mol Biol Int; 1994 Mar; 32(3):545-54. PubMed ID: 8032322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The isolation and characterization of elongation factor eEF-Ts from Krebs-II mouse-ascites-tumor cells and its role in the elongation process.
    Grasmuk H; Nolan RD; Drews J
    Eur J Biochem; 1978 Dec; 92(2):479-90. PubMed ID: 738276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-function relationships of elongation factor Tu. Isolation and activity of the guanine-nucleotide-binding domain.
    Jensen M; Cool RH; Mortensen KK; Clark BF; Parmeggiani A
    Eur J Biochem; 1989 Jun; 182(2):247-55. PubMed ID: 2661226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toward a model for the interaction between elongation factor Tu and the ribosome.
    Weijland A; Parmeggiani A
    Science; 1993 Feb; 259(5099):1311-4. PubMed ID: 8446899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of a kirromycin-resistant elongation factor Tu from Escherichia coli.
    Ivell R; Fasano O; Crechet JB; Parmeggiani A
    Biochemistry; 1981 Mar; 20(5):1355-61. PubMed ID: 7013793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of the phosphorylation sites in elongation factor-2 from rabbit reticulocytes.
    Price NT; Redpath NT; Severinov KV; Campbell DG; Russell JM; Proud CG
    FEBS Lett; 1991 May; 282(2):253-8. PubMed ID: 2037042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of protein synthesis inhibition by didemnin B in vitro.
    SirDeshpande BV; Toogood PL
    Biochemistry; 1995 Jul; 34(28):9177-84. PubMed ID: 7619818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein synthesis elongation factor EF-1 alpha is essential for ubiquitin-dependent degradation of certain N alpha-acetylated proteins and may be substituted for by the bacterial elongation factor EF-Tu.
    Gonen H; Smith CE; Siegel NR; Kahana C; Merrick WC; Chakraburtty K; Schwartz AL; Ciechanover A
    Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7648-52. PubMed ID: 8052636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergism between the GTPase activities of EF-Tu.GTP and EF-G.GTP on empty ribosomes. Elongation factors as stimulators of the ribosomal oscillation between two conformations.
    Mesters JR; Potapov AP; de Graaf JM; Kraal B
    J Mol Biol; 1994 Oct; 242(5):644-54. PubMed ID: 7932721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanistic studies of the translational elongation cycle in mammalian mitochondria.
    Woriax VL; Bullard JM; Ma L; Yokogawa T; Spremulli LL
    Biochim Biophys Acta; 1997 May; 1352(1):91-101. PubMed ID: 9177487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Base 2661 in Escherichia coli 23S rRNA influences the binding of elongation factor Tu during protein synthesis in vivo.
    Tapio S; Isaksson LA
    Eur J Biochem; 1991 Dec; 202(3):981-4. PubMed ID: 1765106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kirromycin, an inhibitor of protein biosynthesis that acts on elongation factor Tu.
    Wolf H; Chinali G; Parmeggiani A
    Proc Natl Acad Sci U S A; 1974 Dec; 71(12):4910-4. PubMed ID: 4373734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An Escherichia coli mutant with an altered elongation factor Tu.
    Lupker JH; Verschoor GJ; de Rooij FW; Rörsch A; Bosch L
    Proc Natl Acad Sci U S A; 1974 Feb; 71(2):460-3. PubMed ID: 4592692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Conformational Change in Elongation Factor Tu Involves Separation of Its Domains.
    Lai J; Ghaemi Z; Luthey-Schulten Z
    Biochemistry; 2017 Nov; 56(45):5972-5979. PubMed ID: 29045140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional properties of phosphorylated elongation factor 2.
    Carlberg U; Nilsson A; Nygård O
    Eur J Biochem; 1990 Aug; 191(3):639-45. PubMed ID: 2390990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of antibiotics, N-acetylaminoacyl-tRNA and other agents on the elongation-factor-Tu dependent and ribosome-dependent GTP hydrolysis promoted by 2'(3')-O-L-phenylalanyladenosine.
    Campuzano S; Modolell J
    Eur J Biochem; 1981 Jun; 117(1):27-31. PubMed ID: 6114863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elongation factor-2 kinase: immunological evidence for the existence of tissue-specific isoforms.
    Hait WN; Ward MD; Trakht IN; Ryazanov AG
    FEBS Lett; 1996 Nov; 397(1):55-60. PubMed ID: 8941713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclic AMP-dependent protein kinase phosphorylates rabbit reticulocyte elongation factor-2 kinase and induces calcium-independent activity.
    Redpath NT; Proud CG
    Biochem J; 1993 Jul; 293 ( Pt 1)(Pt 1):31-4. PubMed ID: 8328970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GTP consumption of elongation factor Tu during translation of heteropolymeric mRNAs.
    Rodnina MV; Wintermeyer W
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):1945-9. PubMed ID: 7892205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.